BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17156290)

  • 1. A semiparametric empirical likelihood method for biased sampling schemes with auxiliary covariates.
    Wang X; Zhou H
    Biometrics; 2006 Dec; 62(4):1149-60. PubMed ID: 17156290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A semiparametric empirical likelihood method for data from an outcome-dependent sampling scheme with a continuous outcome.
    Zhou H; Weaver MA; Qin J; Longnecker MP; Wang MC
    Biometrics; 2002 Jun; 58(2):413-21. PubMed ID: 12071415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
    Kancha RK; von Bubnoff N; Peschel C; Duyster J
    Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
    Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
    Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of EGFR mutation analysis in non-small cell lung cancer.
    Yamamoto H; Toyooka S; Mitsudomi T
    Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiparametric estimation in generalized linear mixed models with auxiliary covariates: a pairwise likelihood approach.
    Liu L; Xiang L
    Biometrics; 2014 Dec; 70(4):910-9. PubMed ID: 25251282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process.
    Hoshi K; Takakura H; Mitani Y; Tatsumi K; Momiyama N; Ichikawa Y; Togo S; Miyagi T; Kawai Y; Kogo Y; Kikuchi T; Kato C; Arakawa T; Uno S; Cizdziel PE; Lezhava A; Ogawa N; Hayashizaki Y; Shimada H
    Clin Cancer Res; 2007 Sep; 13(17):4974-83. PubMed ID: 17785547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on epidermal growth factor receptor mutations in non-small cell lung cancer.
    Riely GJ; Politi KA; Miller VA; Pao W
    Clin Cancer Res; 2006 Dec; 12(24):7232-41. PubMed ID: 17189394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust variance estimation for the case-cohort design.
    Barlow WE
    Biometrics; 1994 Dec; 50(4):1064-72. PubMed ID: 7786988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR assays in lung cancer.
    Dacic S
    Adv Anat Pathol; 2008 Jul; 15(4):241-7. PubMed ID: 18580100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small sample inference for fixed effects from restricted maximum likelihood.
    Kenward MG; Roger JH
    Biometrics; 1997 Sep; 53(3):983-97. PubMed ID: 9333350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
    Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
    Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients.
    Masago K; Fujita S; Kim YH; Ichikawa M; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Mio T; Mishima M
    Cancer Genet Cytogenet; 2009 Dec; 195(2):179-82. PubMed ID: 19963121
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-stage method of estimation for general linear growth curve models.
    Stukel TA; Demidenko E
    Biometrics; 1997 Jun; 53(2):720-8. PubMed ID: 9192460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood methods for regression models with expensive variables missing by design.
    Zhao Y; Lawless JF; McLeish DL
    Biom J; 2009 Feb; 51(1):123-36. PubMed ID: 19197954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling continuous auxiliary covariate data in generalized linear mixed models using the kernel smoother.
    Chen J; Lin CD
    Biom J; 2010 Jun; 52(3):362-76. PubMed ID: 20518048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric analysis of two-level bivariate binary data.
    Naskar M; Das K
    Biometrics; 2006 Dec; 62(4):1004-13. PubMed ID: 17156274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.